Perioperative Rehabilitation Therapy in Patients Undergoing Liver Transplantation
- Conditions
- Liver TransplantationSarcopenia
- Interventions
- Dietary Supplement: BCAA Nutritional InterventionDietary Supplement: Standard Nutritional TherapyBehavioral: Muscle Rehabilitation Training
- Registration Number
- NCT06591507
- Lead Sponsor
- Zhejiang University
- Brief Summary
Patients undergoing liver transplantation frequently experience a reduction in skeletal muscle mass, malnutrition, and decreased levels of physical activity. These complications can adversely affect early postoperative recovery and the therapeutic effect of the transplant. This clinical study aims to investigate the effects of nutritional supplementation and rehabilitation therapy on sarcopenia associated with liver transplantation in adults. The goal is to establish a comprehensive perioperative intervention strategy to reduce the incidence of postoperative sarcopenia and improve transplantation outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 750
- Age between 18 and 70 years.
- Patients with end-stage liver disease who meet the criteria for liver transplantation (for liver cancer cases, only recipients meeting specific standards are included).
- Complete clinical information, including documented pre-transplant muscle status (e.g., preoperative CT scans and handgrip strength tests).
- High compliance with treatment, fully capable of independent action or having at least one assistant.
- No contraindications to the planned interventions.
- Presence of musculoskeletal disorders before transplantation, such as myositis, idiopathic muscle atrophy, or history of hip surgery within the past three months.
- Coexisting severe cardiovascular or cerebrovascular diseases, infectious diseases, or epilepsy.
- Liver transplantation due to autoimmune liver disease or drug-induced liver failure.
- Re-transplantation, multi-organ transplantation, living donor liver transplantation, split liver transplantation, or pediatric liver transplantation.
- ABO-incompatible liver transplantation.
- Incomplete clinical information.
- Difficulty in follow-up.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Preoperative and Postoperative BCAA Nutritional Intervention BCAA Nutritional Intervention - Preoperative and Postoperative BCAA Nutritional Intervention + Postoperative Muscle Rehabilitation BCAA Nutritional Intervention - Preoperative and Postoperative BCAA Nutritional Intervention + Postoperative Muscle Rehabilitation Muscle Rehabilitation Training - Postoperative BCAA Nutritional Intervention BCAA Nutritional Intervention - Postoperative Muscle Rehabilitation Muscle Rehabilitation Training - Standard Nutritional Therapy Standard Nutritional Therapy -
- Primary Outcome Measures
Name Time Method 2-year overall survival From enrollment to the end of follow-up at 2 years At the 2-year mark, record the survival status of each patient (alive or deceased).
- Secondary Outcome Measures
Name Time Method Muscle mass From enrollment to the end of treatment at 6 months Muscle mass can be assessed using various methods, including CT-based Skeletal Muscle Index (SMI) calculation at the L3 vertebra, which measures the cross-sectional area of muscle normalized by height; handgrip strength testing, which evaluates muscle function; bioelectrical impedance analysis (BIA) for body composition; MRI for precise muscle volume measurements; and dual-energy X-ray absorptiometry (DXA) for assessing lean body mass. These methods provide a comprehensive evaluation of muscle health.